共 105 条
[11]
Carpentier F(2018)Chikungunya in Brazil: rheumatologists on the front line J Rheumatol 45 1491-76
[12]
Kassab S(2003)The Stanford health assessment questionnaire (HAQ): a review of its history, issues, progress, and documentation J Rheumatol 30 167-86
[13]
Albert ML(2014)AB1071 the use of visual analogue scale in rheumatic disease: validation of an electronic version: table 1 Ann Rheum Dis 73 1155.2-210
[14]
Lecuit M(1998)Predictors of functional disability in patients with rheumatoid arthritis Arthritis Care Res 11 346-97
[15]
Michault A(2014)Review methods of evaluation of the quality of life in rheumatic diseases Reumatologia/Rheumatology 1 69-1340
[16]
Yactoyo S(2011)Post-chikungunya chronic arthritis—our experience with DMARDs over two year follow up J Assoc Physicians India 59 83-1045
[17]
Staples JE(2018)Rheumatic manifestations associated with chikungunya virus infection: a study of 307 patients with 32-month follow-up (RHUMATOCHIK study) Joint Bone Spine 85 207-1750
[18]
Millot V(2008)Methotrexate and hydroxychloroquine combination therapy in chronic chikungunya arthritis: a 16 week study Indian J Rheumatol 3 93-undefined
[19]
Cibrelus L(2016)Efficacy of combination DMARD therapy vs. hydroxychloroquine monotherapy in chronic persistent chikungunya arthritis: a 24-week randomized controlled open label study Clin Rheumatol 36 1335-undefined
[20]
Pardo PR(2001)The burden of musculoskeletal diseases in the general population of Spain: results from a national survey Ann Rheum Dis 60 1040-undefined